Clinical Application of Cytokine Adsorption Technique in AIDS Patients With Severe Pneumonia and/or Septic Shock

Recruiting now

Conditions studied: AIDS Pneumonia, Septic Shock

In brief

Observing the Real-World Application Effectiveness of Cytokine Immune Adsorption Technology in AIDS Patients with Severe Pneumonia or septic shock.

Key facts

Study ID

NCT06145828

Run by

Guangzhou 8th People's Hospital

People needed

60

Starts

2023-10-23

Expected to finish

2027-10-23

Last updated by the study team

2023-11-24

Who can join

Age: 18 and older, up to 65. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• Confirmed HIV infection;
• Progression to AIDS stage: CD4+ count <200 cells/ul and/or occurrence of AIDS opportunistic infections;
• Age between 18 and 65 years;
• Meeting the diagnosis of severe pneumonia or septic shock:
• The criteria for severe pneumonia diagnosis refer to the 2021 ATS (American Thoracic Society) and IDSA (Infectious Diseases Society of America) guidelines for the treatment of community-acquired pneumonia;
• The criteria for septic shock refer to the Chinese Society of Critical Care Medicine's "Chinese Guidelines for the Emergency Treatment of Sepsis/Septic Shock (2018).

You may not qualify if…

• Coexisting central nervous system lesions, severe liver disease, or cirrhosis;
• Concurrent AIDS-related or unrelated tumors;
• Women who are pregnant or breastfeeding;
• Severe underlying diseases of the heart, lungs, liver, kidneys, etc.;
• Alcohol abuse or drug use;
• The researcher believes that the overall condition of the subject affects the evaluation and completion of the trial.

Where it is running

• Guangzhou Eighth People's Hospital, Guangzhou Medical University — Guangzhou, Guangdong, China (enrolling)

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.